2006 BioFusion Conference
Conference Highlights:
Delegates
from across the globe gathered at the beautiful Washington Duke Inn & Golf Club in Durham, North Carolina for the 2nd annual BioFusion partnering
conference. As the third largest biotech center in the United States,
North Carolina houses over 225 biotech, pharmaceutical, lab testing
and contract research organizations and over 50 medical device companies.
Along with some of the world's leading research universities, the Research
Triangle Park region boasts numerous bioscience innovations and manufacturing
resources, all within a 15 minute drive from the site of BioFusion 2006.
Participating
Companies Included:
|
|
3M
Abeome Corporation
Acordia
Addrenex Pharmaceuticals, Inc.
Aetos Technologies, Inc.
Alston & Bird LLP
Bespak
BioCryst Pharmaceuticals, Inc.
BioQuotient
BioSpace
Biovectra DCL
Business Wire
Calvert Research Institute
Canadian Consulate General
Canadian Consulate--RALDM
Canadian Light Source Inc
Cardinal Health
Castle & Cooke North Carolina LLC
Centers for Disease Control and Prevention
Chimerix Inc.
CIIT Centers for Health Research
Cirrus Pharmaceuticals Inc
CleveMed
Code Refinery
Cognosci, Inc.
Collexis, Inc.
Colliers Pinkard
Constella Group LLC
Copernicus Group IRB
Cordium Links
Council for Entrepreneurial Development (CED)
Cupron, Inc
Daiichi Sankyo Research Institute
Davos Chemical Corporation
Duke University
Eli Lilly and Company
Fish & Richardson PC
Flocel
Genzyme Corporation
Georgia Department of Economic Development
Georgia Medical Center Authority
Georgia State University
GlaxoSmithKline
Global Patent Strategies PLLC
GSK
Harrison Goddard Foote
Hatteras BioCapital
Hunton & Williams
Hutchison Law Group PLLC
IBM
ImmunoBiosciences, Inc.
Intersouth Partners
Kyowa Hakko Kogyo CO., Ltd
|
Life Science Analytics
LIfe Sciences Innovation Center
Life Therapeutics Limited
Manning Selvage & Lee
MBL International Corporation
Medical Device Marketing, LLC
MedPharm Ltd
Merck & Company, Inc.
Metastatix
Metropolitan Research Associates
Millipore
MS&L
Nabi Biopharmaceuticals
National Research Council of Canada - Institute for Biological
Sciences
NC Commerce - International Trade
NCBIO
Neurologix, Inc.
O'Brien/Atkins Associates
Optimus Pharmaceuticals
Pappas Ventures
Patheon Inc.
Perlitz Strategy Group-Americas Inc.
Pfizer Inc
Pharmaplan
Pharmasset
Pounce Corporation
Precision BioSciences
PRENSA LIBRE USA
Primagen Inc.
Roche Applied Science
Scripps Florida
Solvay Pharmaceuticals, Inc.
Southeast BIO
Square 1 Bank
St Charles Pharmaceuticals
Stem Cell Innovations, Inc.
Syngenta Biotechnology, Inc.
Syntherica Corporation
The Caraway Management Group, Inc.
The UAB Research Foundation
Thompson Hine, LLP
Tm Bioscience Corporation
Transpharma Medical Ltd.
UAB Research Foundation
UK Trade & Investment
Vanderbilt University
Vertical*i, Inc.
Warwick Effect Polymers Ltd.
Whiting-Turner Contracting Company
Woodcock Washburn LLP
WYNDEN Pharmaceuticals
Yates Construction
|
2006 Conference Program
Highlights from the 2006 conference:
Technology
Presentations
Companies,
universities and research institutions from across the globe presented
cutting edge technologies available for partnering and licensing.
Technology Showcase
Open House
Senior
executives, scientists and business development representatives for
emerging and established bioscience technologies reached the BioFusion
audience in this interactive pavilion environment.
Technology
Seekers
Large
pharma, medical device and biotechnology leaders spoke to the audience
about the types of technologies they are seeking and discussed their
methodologies for partnering and licensing. Participants:
Merck,
GlaxoSmithKline, Solvay, 3M, Eli Lilly, Pfizer and Genzyme.
Partnering
Meetings
One-to-one
meetings allowed for further partnering discussions and were arranged
prior to the conference through biopartnering.com
or on-site with the help of our meetings staff.
A unique and powerful internet tool, biopartnering.com, allows a proactive
user to prepare for private meetings with potential partners before
attending a conference. You are able to access the password protected
area of the site to research partnering opportunities through keyword
searches of detailed profiles on all companies, contact other users,
arrange private meetings and reserve meeting space at an event.
For registered conference
attendees only.
Golf Tournament &
Networking
BioFusion colleagues gathered for networking
and fun at the Duke
University Golf Club for the first annual BioFusion Golf Tournament
on Sunday, September 17th. That evening, we welcomed all of our guests
at the Washington Duke's Terrace on the Green for our opening cocktail
reception. Monday evening featured a dinner reception in the Durham
community that was another great networking opportunity.
Preliminary
Conference Agenda
(subject to change)
|
Sunday,
September 17th
|
|
9:00
- 2:00
|
BioFusion
Golf Tournament
Duke University Golf Club @ Washington Duke
|
|
4:00 - 5:00
|
Registration
Conference Area
|
|
| 5:00
- 6:00 |
Welcome
Cocktail Reception
Sponsored by Square 1 Bank & Canadian Consulate General
Welcome
by Dr. Kenneth Tindall- Senior Vice President for Science
and Business Development, North Carolina Biotechnology Center
Terrace on the Green
|
| 6:00
- 7:00 |
|
Monday,
September 18th
|
|
7:30
- 8:30
|
Registration
Conference Area
&
Continental Breakfast
Sponsored by MedTRACK
Presidents Gallery
|
|
8:30
- 9:30
|
General
Session
Presidents I & II
Welcome
by Dr. Robert K. McMahan - Senior Advisor to the Governor
for Science and Technology and Executive Director, NC Board
of Science and Technology
&
Keynote Presentation by Richard
N. Kender - Vice President, Business Development &
Corporate Licensing - Merck & Co., Inc.
|
| |
Technology
Presentations
Forest
|
Technology
Showcase & Networking Lounge
Presidents III & IV
9:30AM
to 12:30PM
|
One-To-One
Partnering Meetings
Ambassador Duke
9:30AM
- 12:30PM
Meetings
may be requested via biopartnering.com or on-site at the Meetings
Desk
Private
and semi-private meeting rooms are available in 30 minute or
1 hour blocks.
|
|
9:30
- 9:50
|
Syntherica
- North Carolina
Synthetide(tm) Synthetic Antibodies
|
Warwick Effect Polymers
- UK
Aetos Technologies
- Alabama
Code
Refinery - North Carolina
Cardinal
Health - North Carolina
CleveMed
- Ohio
Agenta
Biotechnologies - Alabama
Copernicus
Group IRB - North Carolina
|
|
9:50
- 10:10
|
Collexis
- South Carolina
Major Advancement in Knowledge Discovery |
|
10:10
- 10:30
|
Precision
BioSciences - North Carolina
Enabling Targeted Genomic Manipulations |
|
10:30
- 10:50
|
TransPharma
Medical - Israel
The ViaDerm System: A Transdermal System for Delivery of Therapuetical
Compounds |
|
10:50
- 11:10
|
Metastatix
- Georgia
Novel
HIV Entry Inhibitor
|
|
11:10
- 11:30
|
Avatar
BioSci - Tennessee
Identification
and Validation of Host Genes Required for Viral Pathogenesis
|
|
11:30
- 11:50
|
Cardinal
Health - North Carolina
GPExTM: Gene Insertion Technology for the Rapid Development of Stable,
High-Expressing Mammalian Cell Lines |
|
11:50
- 12:10
|
Abeome
- Georgia
Platform
for Rapid Selection of Hybridomas
|
|
12:10
- 12:30
|
TBD
|
|
12:30
-
2:00
|
Lunch
Presentation
& Panel
Presidents I & II
Bioscience Developments & Partnering Opportunities in the
Southern U.S.
Sponsored by Thompson Hine LLP
Moderator:
Frank McDaniel - Thompson
Hine, LLP; Chair - BioSouth, Inc.
Panelists:
Dr. Harry Orf - Vice President for Scientific Operations
and Professor of Chemistry, Scripps
Research Institute - Scripps Florida
Clyde Higgs - Vice President for Business Development,
Castle & Cooke North Carolina; North
Carolina Research Campus
|
| |
Technology
Presentations
Forest |
Regional
Presentations
Ambassador Allen
|
One-To-One
Partnering Meetings
Ambassador Duke
2:00PM
- 5:00PM
Meetings
may be requested via biopartnering.com or on-site at the Meetings
Desk
Private
and semi-private meeting rooms are available in 30 minute or 1
hour blocks.
|
| 2:00
- 2:20 |
TM
BioScience - Canada
Development
and Commercialization of BioMarkers and Disease Panels
|
Opportunities
in North Carolina's Growing Bioscience Industry
Monica
P. Doss - President and CEO, Council
for Entrepreneurial Development
John
Richert
- Vice President, Business & Technology Development, North
Carolina
Biotechnology Center
Sam
Taylor
- President, North
Carolina Biosciences Organization
|
| 2:20
- 2:40 |
Stem
Cell Innovations - Texas
Human Pluripotent Stem Cells for Use in Drug Discovery and Cell
Therapy |
| 2:40
- 3:00 |
Cognosci
- North Carolina
Novel
Therapeutics for Multiple Sclerosis
|
| 3:00
- 3:20 |
ImmunoBiosciences
- North Carolina
Immune Complex Vaccine Technology |
Bioscience
Partnering Opportunities in Canada
Dr.
Colleen Christensen - Lifesciences Industrial Liaison Scientist,
Canadian Light
Source Inc.
Scott
Ferguson - Business Relations, National
Research Council of Canada - Institute for Biological Sciences
|
| 3:20
- 3:40 |
WYNDEN
Pharmaceuticals - Georgia
Therapeutics for Electrolyte Repletion |
| 3:40
- 4:00 |
Liquidia
Technologies - North Carolina
PRINT
Particles and the Treatment of Human Disease
|
| 4:00
- 5:00 |
Panel:
Getting Products from Clinic to the Market
(Without necessarily relying on a big pharma partnership)
Presidents I & II
Moderator:
Bill Wofford - Life Sciences Practice Group Leader, Hutchison
Law Group
Panelists:
Jeff Abbey - Vice President of Business Development, Argos
Therapeutics
Ben Bonifant - Vice President, Campbell
Alliance
David Pierson - Partner, Intersouth
Partners
Susan Lillard Thomason - Executive Director, Global Business
Development, NovaQuest
|
| 5:00
-
7:30 |
BioFusion
Dinner Reception
Sponsored by Duke University
Welcome by MaryAnn Black - Associate Vice President for Community
Affairs,
Duke University Health System
Presidents Terrace |
|
Tuesday,
September 19th
|
|
7:30
- 8:30
|
Registration
Conference Area
&
Continental Breakfast
Sponsored by MedTRACK
Presidents Gallery
|
|
8:30
- 9:30
|
General
Session
Presidents I & II
Welcome
& Panel: Changes in Global Partnering for the Bioscience
Industry
Moderator
- Dr. Abel De La Rosa - Senior Vice President for Business
Development & Scientific Affairs, Pharmasset
Dr. Nancy Shepherd - Director, Technology Licensing,
Worldwide Business Development, GlaxoSmithKline
Dr. Michael A. Recny - Vice President of Corporate Development,
Trimeris,
Inc.
Dr. Roman Szumski - Vice President of Life Sciences,
National
Research Council Canada
|
| |
Technology
Seekers' Presentations
Presidents
I & II
|
One-To-One
Partnering Meetings
Ambassador Duke
9:30AM
- 4:30PM
Meetings
may be requested via biopartnering.com or on-site at the Meetings
Desk
Private
and semi-private meeting rooms are available in 30 minute or
1 hour blocks.
|
|
9:30
- 9:50
|
Merck
& Co. Inc.
Pamela
Demain - Executive Director, Corporate Licensing
|
|
9:50
- 10:10
|
3M
Health Care
Susan
Paquette - Commercialization Director
|
|
10:10
- 10:30
|
Solvay
Pharmaceuticals
Dr.
Joseph C. Nolan - Director, Business Development |
|
10:30
- 10:50
|
GlaxoSmithKline
Gregg
Davis - Director, Worldwide Business Development |
|
10:50
- 11:10
|
Genzyme
Dr.
Bruce M. Pratt - Vice President, Science Development |
|
11:10
- 11:30
|
Eli
Lilly & Company
Mark
A. Miller - Senior Director, Corporate Business Development |
|
11:30
- 11:50
|
Pfizer
Dr.
Mary L. Mayer - Associate Director, Strategic Alliances |
|
11:50
- 12:10
|
TBD |
| 12:10
-
1:30 |
Buffet
Lunch Available
Presidents Gallery
|
BioFusion
Workshop
(Registration Required)
Going Global - Considerations For Conducting International Clinical
Trials
Ambassador Allen
Penny
Smith, Esq. - Thompson Hine, LLP
Marc
Ingham, Esq. - Manager, Legal Agreements, Duke Clinical Research
Institute
Mary Ann Sellers - MSN Operations Manager, Duke Clinical
Research Institute
|
BioFusion
Workshop
(Registration Required)
Opportunities in the
Canadian and U.S. Neutraceuticals/Neutriscience Industries
Forest
Moderator:
Dr. A. Elizabeth Robinson - Trade Commissioner, Canadian Consulate--RALDM
Dr.
Michael Mayne - Director of Research, National Research Council
Canada (NRC) Institute for Nutrisciences and Health
Clyde
Higgs - Vice President, Business Development, North Carolina
Research Campus
Dr.
Roman Szumski - VP Life Sciences, National Research Council
Canada
|
| 1:30
- 4:30 |
|
2006 Conference Presenters
The Technology Seekers presentations
featured business development executives from leading device, biotech
and pharmaceutical companies with an overview of their partnering and
licensing needs and processes. Participants included:
Pamela
Demain - Executive Director, Corporate Licensing - Merck
& Co. Inc.
Dr.
Joseph C. Nolan - Director, Business Development- Solvay Pharmaceuticals
Gregg
Davis - Director, Worldwide Business Development - GlaxoSmithKline
Susan Paquette
- Commercialization Director - 3M Health Care
Mark A. Miller
- Senior Director, Corporate Business Development - Eli Lilly
& Company
Dr.
Mary L. Mayer - Associate Director, Strategic Alliances - Pfizer
Dr. Bruce M. Pratt
- Vice President, Science Development - Genzyme
|
